Carcinoembryonic antigen (CEA) in explants of human breast cancer: comparison of immunohistochemical detection and release during short-term culture.

Por Miller, W. R., Sturgeon, C. M., Walker, R. A.
Publicado em 1983

Raised carcinoembryonic antigen level as an indicator of recurrent disease in follow up of patients with colorectal cancer.

Por Miles, W F, Greig, J D, Seth, J, Sturgeon, C, Nixon, S J
Publicado em 1995

Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update

Por Duffy, MJ, Lamerz, R, Haglund, C, Nicolini, A, Kalousová, M, Holubec, L, Sturgeon, C
Publicado em 2014

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.

Por Fisken, J., Leonard, R. C., Stewart, M., Beattie, G. J., Sturgeon, C., Aspinall, L., Roulston, J. E.
Publicado em 1993

The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125.

Por Fisken, J., Roulston, J. E., Sturgeon, C., Badley, R. A., Jönrup, I., Aspinall, L., Leonard, R. C.
Publicado em 1993

Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop

Por Berger, P., Paus, E., Hemken, P. M., Sturgeon, C., Stewart, W. W., Skinner, J. P., Harwick, L. C., Saldana, S. C., Ramsay, C. S., Rupprecht, K. R., Olsen, K. H., Bidart, J.-M., Stenman, U.-H.
Publicado em 2013